世界の肝抗ウイルス薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatic Antiviral Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4301 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、肝抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院、ホームケア、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肝抗ウイルス薬の市場動向 ・企業の競争状況、市場シェア ・肝抗ウイルス薬の種類別市場規模と予測2016-2027（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他） ・肝抗ウイルス薬の用途別市場規模と予測2016-2027（病院、ホームケア、診療所、その他） ・肝抗ウイルス薬の北米市場規模2016-2027（アメリカ、カナダ） ・肝抗ウイルス薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝抗ウイルス薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝抗ウイルス薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝抗ウイルス薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva Pharmaceutical Industries、Bristol-Myers Squibb、Zydus Cadila、Cipla、Prinston Pharmaceutical、Hetero Drug、Aurobindo Pharma、Apotex、Gilead Sciences、Mylan） ・結論

It is an antiviral drug used to treat hepatitis virus infections.

Market Analysis and Insights: Global Hepatic Antiviral Drug Market
The global Hepatic Antiviral Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatic Antiviral Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatic Antiviral Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatic Antiviral Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatic Antiviral Drug market.

Global Hepatic Antiviral Drug Scope and Market Size
Hepatic Antiviral Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatic Antiviral Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Entecavir
Tenofovir
lamivudine
Adefovir
Telbivudine
Others

Segment by Application
Hospitals
Homecare
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva Pharmaceutical Industries
Bristol-Myers Squibb
Zydus Cadila
Cipla
Prinston Pharmaceutical
Hetero Drug
Aurobindo Pharma
Apotex
Gilead Sciences
Mylan

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatic Antiviral Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 lamivudine
1.2.5 Adefovir
1.2.6 Telbivudine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hepatic Antiviral Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatic Antiviral Drug Market Perspective (2016-2027)
2.2 Hepatic Antiviral Drug Growth Trends by Regions
2.2.1 Hepatic Antiviral Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatic Antiviral Drug Historic Market Share by Regions (2016-2021)
2.2.3 Hepatic Antiviral Drug Forecasted Market Size by Regions (2022-2027)
2.3 Hepatic Antiviral Drug Industry Dynamic
2.3.1 Hepatic Antiviral Drug Market Trends
2.3.2 Hepatic Antiviral Drug Market Drivers
2.3.3 Hepatic Antiviral Drug Market Challenges
2.3.4 Hepatic Antiviral Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatic Antiviral Drug Players by Revenue
3.1.1 Global Top Hepatic Antiviral Drug Players by Revenue (2016-2021)
3.1.2 Global Hepatic Antiviral Drug Revenue Market Share by Players (2016-2021)
3.2 Global Hepatic Antiviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatic Antiviral Drug Revenue
3.4 Global Hepatic Antiviral Drug Market Concentration Ratio
3.4.1 Global Hepatic Antiviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatic Antiviral Drug Revenue in 2020
3.5 Hepatic Antiviral Drug Key Players Head office and Area Served
3.6 Key Players Hepatic Antiviral Drug Product Solution and Service
3.7 Date of Enter into Hepatic Antiviral Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatic Antiviral Drug Breakdown Data by Type
4.1 Global Hepatic Antiviral Drug Historic Market Size by Type (2016-2021)
4.2 Global Hepatic Antiviral Drug Forecasted Market Size by Type (2022-2027)

5 Hepatic Antiviral Drug Breakdown Data by Application
5.1 Global Hepatic Antiviral Drug Historic Market Size by Application (2016-2021)
5.2 Global Hepatic Antiviral Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatic Antiviral Drug Market Size (2016-2027)
6.2 North America Hepatic Antiviral Drug Market Size by Type
6.2.1 North America Hepatic Antiviral Drug Market Size by Type (2016-2021)
6.2.2 North America Hepatic Antiviral Drug Market Size by Type (2022-2027)
6.2.3 North America Hepatic Antiviral Drug Market Size by Type (2016-2027)
6.3 North America Hepatic Antiviral Drug Market Size by Application
6.3.1 North America Hepatic Antiviral Drug Market Size by Application (2016-2021)
6.3.2 North America Hepatic Antiviral Drug Market Size by Application (2022-2027)
6.3.3 North America Hepatic Antiviral Drug Market Size by Application (2016-2027)
6.4 North America Hepatic Antiviral Drug Market Size by Country
6.4.1 North America Hepatic Antiviral Drug Market Size by Country (2016-2021)
6.4.2 North America Hepatic Antiviral Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hepatic Antiviral Drug Market Size (2016-2027)
7.2 Europe Hepatic Antiviral Drug Market Size by Type
7.2.1 Europe Hepatic Antiviral Drug Market Size by Type (2016-2021)
7.2.2 Europe Hepatic Antiviral Drug Market Size by Type (2022-2027)
7.2.3 Europe Hepatic Antiviral Drug Market Size by Type (2016-2027)
7.3 Europe Hepatic Antiviral Drug Market Size by Application
7.3.1 Europe Hepatic Antiviral Drug Market Size by Application (2016-2021)
7.3.2 Europe Hepatic Antiviral Drug Market Size by Application (2022-2027)
7.3.3 Europe Hepatic Antiviral Drug Market Size by Application (2016-2027)
7.4 Europe Hepatic Antiviral Drug Market Size by Country
7.4.1 Europe Hepatic Antiviral Drug Market Size by Country (2016-2021)
7.4.2 Europe Hepatic Antiviral Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatic Antiviral Drug Market Size (2016-2027)
8.2 Asia-Pacific Hepatic Antiviral Drug Market Size by Type
8.2.1 Asia-Pacific Hepatic Antiviral Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatic Antiviral Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatic Antiviral Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatic Antiviral Drug Market Size by Application
8.3.1 Asia-Pacific Hepatic Antiviral Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatic Antiviral Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatic Antiviral Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatic Antiviral Drug Market Size by Region
8.4.1 Asia-Pacific Hepatic Antiviral Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatic Antiviral Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatic Antiviral Drug Market Size (2016-2027)
9.2 Latin America Hepatic Antiviral Drug Market Size by Type
9.2.1 Latin America Hepatic Antiviral Drug Market Size by Type (2016-2021)
9.2.2 Latin America Hepatic Antiviral Drug Market Size by Type (2022-2027)
9.2.3 Latin America Hepatic Antiviral Drug Market Size by Type (2016-2027)
9.3 Latin America Hepatic Antiviral Drug Market Size by Application
9.3.1 Latin America Hepatic Antiviral Drug Market Size by Application (2016-2021)
9.3.2 Latin America Hepatic Antiviral Drug Market Size by Application (2022-2027)
9.3.3 Latin America Hepatic Antiviral Drug Market Size by Application (2016-2027)
9.4 Latin America Hepatic Antiviral Drug Market Size by Country
9.4.1 Latin America Hepatic Antiviral Drug Market Size by Country (2016-2021)
9.4.2 Latin America Hepatic Antiviral Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatic Antiviral Drug Market Size (2016-2027)
10.2 Middle East & Africa Hepatic Antiviral Drug Market Size by Type
10.2.1 Middle East & Africa Hepatic Antiviral Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatic Antiviral Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatic Antiviral Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatic Antiviral Drug Market Size by Application
10.3.1 Middle East & Africa Hepatic Antiviral Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatic Antiviral Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatic Antiviral Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatic Antiviral Drug Market Size by Country
10.4.1 Middle East & Africa Hepatic Antiviral Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatic Antiviral Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Details
11.1.2 Teva Pharmaceutical Industries Business Overview
11.1.3 Teva Pharmaceutical Industries Hepatic Antiviral Drug Introduction
11.1.4 Teva Pharmaceutical Industries Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.1.5 Teva Pharmaceutical Industries Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Hepatic Antiviral Drug Introduction
11.2.4 Bristol-Myers Squibb Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Details
11.3.2 Zydus Cadila Business Overview
11.3.3 Zydus Cadila Hepatic Antiviral Drug Introduction
11.3.4 Zydus Cadila Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.3.5 Zydus Cadila Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Hepatic Antiviral Drug Introduction
11.4.4 Cipla Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.4.5 Cipla Recent Development
11.5 Prinston Pharmaceutical
11.5.1 Prinston Pharmaceutical Company Details
11.5.2 Prinston Pharmaceutical Business Overview
11.5.3 Prinston Pharmaceutical Hepatic Antiviral Drug Introduction
11.5.4 Prinston Pharmaceutical Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.5.5 Prinston Pharmaceutical Recent Development
11.6 Hetero Drug
11.6.1 Hetero Drug Company Details
11.6.2 Hetero Drug Business Overview
11.6.3 Hetero Drug Hepatic Antiviral Drug Introduction
11.6.4 Hetero Drug Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.6.5 Hetero Drug Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Hepatic Antiviral Drug Introduction
11.7.4 Aurobindo Pharma Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.7.5 Aurobindo Pharma Recent Development
11.8 Apotex
11.8.1 Apotex Company Details
11.8.2 Apotex Business Overview
11.8.3 Apotex Hepatic Antiviral Drug Introduction
11.8.4 Apotex Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.8.5 Apotex Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Hepatic Antiviral Drug Introduction
11.9.4 Gilead Sciences Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.9.5 Gilead Sciences Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Hepatic Antiviral Drug Introduction
11.10.4 Mylan Revenue in Hepatic Antiviral Drug Business (2016-2021)
11.10.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatic Antiviral Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Entecavir
Table 3. Key Players of Tenofovir
Table 4. Key Players of lamivudine
Table 5. Key Players of Adefovir
Table 6. Key Players of Telbivudine
Table 7. Key Players of Others
Table 8. Global Hepatic Antiviral Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hepatic Antiviral Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hepatic Antiviral Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hepatic Antiviral Drug Market Share by Regions (2016-2021)
Table 12. Global Hepatic Antiviral Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hepatic Antiviral Drug Market Share by Regions (2022-2027)
Table 14. Hepatic Antiviral Drug Market Trends
Table 15. Hepatic Antiviral Drug Market Drivers
Table 16. Hepatic Antiviral Drug Market Challenges
Table 17. Hepatic Antiviral Drug Market Restraints
Table 18. Global Hepatic Antiviral Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hepatic Antiviral Drug Market Share by Players (2016-2021)
Table 20. Global Top Hepatic Antiviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatic Antiviral Drug as of 2020)
Table 21. Ranking of Global Top Hepatic Antiviral Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hepatic Antiviral Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hepatic Antiviral Drug Product Solution and Service
Table 25. Date of Enter into Hepatic Antiviral Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hepatic Antiviral Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Hepatic Antiviral Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hepatic Antiviral Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hepatic Antiviral Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hepatic Antiviral Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Hepatic Antiviral Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hepatic Antiviral Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hepatic Antiviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hepatic Antiviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hepatic Antiviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hepatic Antiviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hepatic Antiviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hepatic Antiviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hepatic Antiviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hepatic Antiviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hepatic Antiviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hepatic Antiviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hepatic Antiviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hepatic Antiviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hepatic Antiviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hepatic Antiviral Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hepatic Antiviral Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hepatic Antiviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hepatic Antiviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hepatic Antiviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hepatic Antiviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hepatic Antiviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatic Antiviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hepatic Antiviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hepatic Antiviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hepatic Antiviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hepatic Antiviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hepatic Antiviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Teva Pharmaceutical Industries Company Details
Table 66. Teva Pharmaceutical Industries Business Overview
Table 67. Teva Pharmaceutical Industries Hepatic Antiviral Drug Product
Table 68. Teva Pharmaceutical Industries Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 69. Teva Pharmaceutical Industries Recent Development
Table 70. Bristol-Myers Squibb Company Details
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb Hepatic Antiviral Drug Product
Table 73. Bristol-Myers Squibb Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Zydus Cadila Company Details
Table 76. Zydus Cadila Business Overview
Table 77. Zydus Cadila Hepatic Antiviral Drug Product
Table 78. Zydus Cadila Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 79. Zydus Cadila Recent Development
Table 80. Cipla Company Details
Table 81. Cipla Business Overview
Table 82. Cipla Hepatic Antiviral Drug Product
Table 83. Cipla Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 84. Cipla Recent Development
Table 85. Prinston Pharmaceutical Company Details
Table 86. Prinston Pharmaceutical Business Overview
Table 87. Prinston Pharmaceutical Hepatic Antiviral Drug Product
Table 88. Prinston Pharmaceutical Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 89. Prinston Pharmaceutical Recent Development
Table 90. Hetero Drug Company Details
Table 91. Hetero Drug Business Overview
Table 92. Hetero Drug Hepatic Antiviral Drug Product
Table 93. Hetero Drug Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 94. Hetero Drug Recent Development
Table 95. Aurobindo Pharma Company Details
Table 96. Aurobindo Pharma Business Overview
Table 97. Aurobindo Pharma Hepatic Antiviral Drug Product
Table 98. Aurobindo Pharma Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 99. Aurobindo Pharma Recent Development
Table 100. Apotex Company Details
Table 101. Apotex Business Overview
Table 102. Apotex Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 103. Apotex Recent Development
Table 104. Gilead Sciences Company Details
Table 105. Gilead Sciences Business Overview
Table 106. Gilead Sciences Hepatic Antiviral Drug Product
Table 107. Gilead Sciences Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 108. Gilead Sciences Recent Development
Table 109. Mylan Company Details
Table 110. Mylan Business Overview
Table 111. Mylan Hepatic Antiviral Drug Product
Table 112. Mylan Revenue in Hepatic Antiviral Drug Business (2016-2021) & (US$ Million)
Table 113. Mylan Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatic Antiviral Drug Market Share by Type: 2020 VS 2027
Figure 2. Entecavir Features
Figure 3. Tenofovir Features
Figure 4. lamivudine Features
Figure 5. Adefovir Features
Figure 6. Telbivudine Features
Figure 7. Others Features
Figure 8. Global Hepatic Antiviral Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Hepatic Antiviral Drug Report Years Considered
Figure 14. Global Hepatic Antiviral Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Hepatic Antiviral Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Hepatic Antiviral Drug Market Share by Regions: 2020 VS 2027
Figure 17. Global Hepatic Antiviral Drug Market Share by Regions (2022-2027)
Figure 18. Global Hepatic Antiviral Drug Market Share by Players in 2020
Figure 19. Global Top Hepatic Antiviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatic Antiviral Drug as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Hepatic Antiviral Drug Revenue in 2020
Figure 21. Global Hepatic Antiviral Drug Revenue Market Share by Type (2016-2021)
Figure 22. Global Hepatic Antiviral Drug Revenue Market Share by Type (2022-2027)
Figure 23. North America Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Hepatic Antiviral Drug Market Share by Type (2016-2027)
Figure 25. North America Hepatic Antiviral Drug Market Share by Application (2016-2027)
Figure 26. North America Hepatic Antiviral Drug Market Share by Country (2016-2027)
Figure 27. United States Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Hepatic Antiviral Drug Market Share by Type (2016-2027)
Figure 31. Europe Hepatic Antiviral Drug Market Share by Application (2016-2027)
Figure 32. Europe Hepatic Antiviral Drug Market Share by Country (2016-2027)
Figure 33. Germany Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Hepatic Antiviral Drug Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Hepatic Antiviral Drug Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Hepatic Antiviral Drug Market Share by Region (2016-2027)
Figure 43. China Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Hepatic Antiviral Drug Market Share by Type (2016-2027)
Figure 51. Latin America Hepatic Antiviral Drug Market Share by Application (2016-2027)
Figure 52. Latin America Hepatic Antiviral Drug Market Share by Country (2016-2027)
Figure 53. Mexico Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Hepatic Antiviral Drug Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Hepatic Antiviral Drug Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Hepatic Antiviral Drug Market Share by Country (2016-2027)
Figure 59. Turkey Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Hepatic Antiviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 64. Zydus Cadila Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 65. Cipla Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 66. Prinston Pharmaceutical Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 67. Hetero Drug Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 68. Aurobindo Pharma Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 69. Apotex Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 71. Mylan Revenue Growth Rate in Hepatic Antiviral Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---